One Feb­ru­ary FDA ad­comm meet­ing is de­layed, an­oth­er can­celed

An FDA ad­vi­so­ry com­mit­tee meet­ing for a kid­ney drug has been can­celed, and an­oth­er meet­ing to dis­cuss opi­oids has been de­layed, amid on­go­ing con­fu­sion and …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER